Literature DB >> 10420594

Structure of an antigenic teichoic acid shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium.

Y Wang1, J Huebner, A O Tzianabos, G Martirosian, D L Kasper, G B Pier.   

Abstract

A shared antigenic teichoic acid, previously found to be a surface capsule-like polysaccharide, was isolated from clinical isolates of Enterococcus faecalis and vancomycin-resistant E. faecium. It was composed of glucose, glycerol, and phosphate as determined by chemical and GC-MS analysis. The repeating-unit structure was elucidated by a series of 1H, 13C, and 31P NMR spectroscopy to be the following: [formula: see text]

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10420594     DOI: 10.1016/s0008-6215(99)00046-4

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  13 in total

1.  Alanine esters of enterococcal lipoteichoic acid play a role in biofilm formation and resistance to antimicrobial peptides.

Authors:  Francesca Fabretti; Christian Theilacker; Lucilla Baldassarri; Zbigniew Kaczynski; Andrea Kropec; Otto Holst; Johannes Huebner
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

2.  Intrinsic resistance of Enterococcus faecalis strains to ΦEf11 phage endolysin is associated with the presence of ΦEf11 prophage.

Authors:  Hongming Zhang; Roy H Stevens
Journal:  Arch Virol       Date:  2020-11-09       Impact factor: 2.574

3.  Naturally acquired antibodies against four Enterococcus faecalis capsular polysaccharides in healthy human sera.

Authors:  Markus Hufnagel; Andrea Kropec; Christian Theilacker; Johannes Huebner
Journal:  Clin Diagn Lab Immunol       Date:  2005-08

4.  Opsonic antibodies to Enterococcus faecalis strain 12030 are directed against lipoteichoic acid.

Authors:  Christian Theilacker; Zbigniew Kaczynski; Andrea Kropec; Francesca Fabretti; Tatjana Sange; Otto Holst; Johannes Huebner
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

5.  Prophylactic and therapeutic efficacy of antibodies to a capsular polysaccharide shared among vancomycin-sensitive and -resistant enterococci.

Authors:  J Huebner; A Quaas; W A Krueger; D A Goldmann; G B Pier
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

6.  Evidence that the enterococcal polysaccharide antigen gene (epa) cluster is widespread in Enterococcus faecalis and influences resistance to phagocytic killing of E. faecalis.

Authors:  Fang Teng; Karen D Jacques-Palaz; George M Weinstock; Barbara E Murray
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

7.  Serological and genetic diversity of capsular polysaccharides in Enterococcus faecalis.

Authors:  Markus Hufnagel; Lynn E Hancock; Stefanie Koch; Christian Theilacker; Michael S Gilmore; Johannes Huebner
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

8.  Capsular polysaccharide production in Enterococcus faecalis and contribution of CpsF to capsule serospecificity.

Authors:  Lance R Thurlow; Vinai Chittezham Thomas; Lynn E Hancock
Journal:  J Bacteriol       Date:  2009-08-14       Impact factor: 3.490

9.  Wall teichoic acids of Staphylococcus aureus limit recognition by the drosophila peptidoglycan recognition protein-SA to promote pathogenicity.

Authors:  Magda L Atilano; James Yates; Marcus Glittenberg; Sergio R Filipe; Petros Ligoxygakis
Journal:  PLoS Pathog       Date:  2011-12-01       Impact factor: 6.823

10.  Immunochemical characterization of polysaccharide antigens from six clinical strains of Enterococci.

Authors:  Carolyn T Hsu; Amanda L Ganong; Barbara Reinap; Zafiria Mourelatos; Johannes Huebner; Julia Y Wang
Journal:  BMC Microbiol       Date:  2006-07-12       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.